Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: --
291,70 DKK
Kurs
Kurs
-0,24%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
409,95 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 07.07.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 11.08.2026 0 Monate | 11.08.2026 | 0 Monate | 291,70 305 | 291,70 | 305 | 4,559479 | BERENBERG | ||
| Novo Nordisk AS | 07.08.2026 0 Monate | 07.08.2026 | 0 Monate | 291,70 | 291,70 | -- | DZ BANK | |||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 291,70 285 | 291,70 | 285 | 2,29688 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 291,70 290 | 291,70 | 290 | 0,582791 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 291,70 200 | 291,70 | 200 | 31,436407 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 291,70 332 | 291,70 | 332 | 13,815564 | UBS | ||
| Novo Nordisk AS | 05.08.2026 12 Monate | 05.08.2026 | 12 Monate | 291,70 310 | 291,70 | 310 | 6,273569 | BARCLAYS | ||
| Novo Nordisk AS | 04.08.2026 12 Monate | 04.08.2026 | 12 Monate | 291,70 285 | 291,70 | 285 | 2,29688 | JEFFERIES | ||
| Novo Nordisk AS | 04.08.2026 0 Monate | 04.08.2026 | 0 Monate | 291,70 332 | 291,70 | 332 | 13,815564 | UBS | ||
| Novo Nordisk AS | 31.07.2026 0 Monate | 31.07.2026 | 0 Monate | 291,70 250 | 291,70 | 250 | 14,295509 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 291,70 290 | 291,70 | 290 | 0,582791 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 291,70 332 | 291,70 | 332 | 13,815564 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 291,70 285 | 291,70 | 285 | 2,29688 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 291,70 250 | 291,70 | 250 | 14,295509 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 291,70 290 | 291,70 | 290 | 0,582791 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 291,70 325 | 291,70 | 325 | 11,415838 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 291,70 290 | 291,70 | 290 | 0,582791 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 291,70 250 | 291,70 | 250 | 14,295509 | JPMORGAN | ||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 291,70 250 | 291,70 | 250 | 14,295509 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 291,70 305 | 291,70 | 305 | 4,559479 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 291,70 290 | 291,70 | 290 | 0,582791 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 291,70 290 | 291,70 | 290 | 0,582791 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 291,70 300 | 291,70 | 300 | 2,845389 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 291,70 175 | 291,70 | 175 | 40,006856 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 291,70 290 | 291,70 | 290 | 0,582791 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 291,70 290 | 291,70 | 290 | 0,582791 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 291,70 | 291,70 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 291,70 300 | 291,70 | 300 | 2,845389 | BARCLAYS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 291,70 332 | 291,70 | 332 | 13,815564 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 291,70 250 | 291,70 | 250 | 14,295509 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 291,70 263 | 291,70 | 263 | 9,838876 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 291,70 250 | 291,70 | 250 | 14,295509 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 291,70 175 | 291,70 | 175 | 40,006856 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 291,70 300 | 291,70 | 300 | 2,845389 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 291,70 250 | 291,70 | 250 | 14,295509 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 291,70 275 | 291,70 | 275 | 5,72506 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 291,70 250 | 291,70 | 250 | 14,295509 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 291,70 332 | 291,70 | 332 | 13,815564 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 291,70 263 | 291,70 | 263 | 9,838876 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 291,70 250 | 291,70 | 250 | 14,295509 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 291,70 275 | 291,70 | 275 | 5,72506 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 291,70 250 | 291,70 | 250 | 14,295509 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 291,70 300 | 291,70 | 300 | 2,845389 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 291,70 250 | 291,70 | 250 | 14,295509 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 291,70 260 | 291,70 | 260 | 10,867329 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 291,70 400 | 291,70 | 400 | 37,127185 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 291,70 250 | 291,70 | 250 | 14,295509 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 291,70 400 | 291,70 | 400 | 37,127185 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 291,70 332 | 291,70 | 332 | 13,815564 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 291,70 340 | 291,70 | 340 | 16,558108 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 291,70 275 | 291,70 | 275 | 5,72506 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 291,70 350 | 291,70 | 350 | 19,986287 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 291,70 340 | 291,70 | 340 | 16,558108 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 291,70 275 | 291,70 | 275 | 5,72506 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 291,70 250 | 291,70 | 250 | 14,295509 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 291,70 340 | 291,70 | 340 | 16,558108 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 291,70 340 | 291,70 | 340 | 16,558108 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 291,70 340 | 291,70 | 340 | 16,558108 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 291,70 340 | 291,70 | 340 | 16,558108 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 291,70 400 | 291,70 | 400 | 37,127185 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 291,70 275 | 291,70 | 275 | 5,72506 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 291,70 360 | 291,70 | 360 | 23,414467 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 291,70 360 | 291,70 | 360 | 23,414467 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 291,70 360 | 291,70 | 360 | 23,414467 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 291,70 350 | 291,70 | 350 | 19,986287 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 291,70 332 | 291,70 | 332 | 13,815564 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 291,70 475 | 291,70 | 475 | 62,838533 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 291,70 332 | 291,70 | 332 | 13,815564 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 291,70 350 | 291,70 | 350 | 19,986287 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 291,70 350 | 291,70 | 350 | 19,986287 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 291,70 350 | 291,70 | 350 | 19,986287 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 291,70 360 | 291,70 | 360 | 23,414467 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 291,70 390 | 291,70 | 390 | 33,699006 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 291,70 350 | 291,70 | 350 | 19,986287 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 291,70 436 | 291,70 | 436 | 49,468632 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 291,70 415 | 291,70 | 415 | 42,269455 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 291,70 360 | 291,70 | 360 | 23,414467 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 291,70 270 | 291,70 | 270 | 7,43915 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 291,70 390 | 291,70 | 390 | 33,699006 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 291,70 390 | 291,70 | 390 | 33,699006 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 291,70 360 | 291,70 | 360 | 23,414467 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 291,70 415 | 291,70 | 415 | 42,269455 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 291,70 475 | 291,70 | 475 | 62,838533 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 291,70 350 | 291,70 | 350 | 19,986287 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 291,70 390 | 291,70 | 390 | 33,699006 | UBS |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M